Since the coronavirus (COVID-19) outbreak keeps on spreading all through the world, scientists have been crafting varied technologies mainly focusing on AI for an approach to acknowledge the difficulties of the epidemic. In this current worldwide emergency, the clinical business is searching for new advancements to screen and combat COVID-19 contamination. Strategies used by artificial intelligence can stretch screen the spread of the infection, distinguish highly infected patients, and be compelling in supervising the illness continuously. The artificial intelligence anticipation can further be used for passing dangers by sufficiently dissecting information from past sufferers. International patient support with recommendations for population testing, medical care, notification, and infection control can help fight this deadly virus. We proposed the hybrid deep learning method to diagnose COVID-19. The layered approach is used here to measure the symptom level of the patients and to analyze the patient image data whether he/she is positive with COVID-19. This work utilizes smart AI techniques to predict and diagnose the coronavirus rapidly by the Oura smart ring within 24 h. In the laboratory, a coronavirus rapid test is prepared with the help of a deep learning model using the RNN and CNN algorithms to diagnose the coronavirus rapidly and accurately. The result shows the value 0 or 1. The result 1 indicates the person is affected with coronavirus and the result 0 indicates the person is not affected with coronavirus. X-Ray and CT image classifications are considered here so that the threshold value is utilized for identifying an individual’s health condition from the initial stage to a severe stage. Threshold value 0.5 is used to identify coronavirus initial stage condition and 1 is used to identify the coronavirus severe condition of the patient. The proposed methods are utilized for four weighting parameters to reduce both false positive and false negative image classification results for rapid and accurate diagnosis of COVID-19. © 2021, The Author(s), under exclusive licence to Springer-Verlag London Ltd. part of Springer Nature.